1,3 butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development

Circulation

Volumn 93, Issue 3, 1996, Pages 552-557

  Penn, Arthur ^a,b   Snyder, Carroll A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

arteriosclerosis; butadiene; sidestream smoke

Indexed keywords

1,3 BUTADIENE; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHICKEN; CIGARETTE SMOKING; CONTROLLED STUDY; HEART DISEASE; ISCHEMIC HEART DISEASE; MALE; MORBIDITY; MORTALITY; NEGRO; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

EID: 0030020064     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.3.552     Document Type: Article

References (36)

1. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol. 1994;24:546-554.
2. Penn A, Snyder CA. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation. 1993;88:1820-1825.
3. Penn A, Chen LC, Snyder CA. Inhalation of steady-state side-stream smoke from one cigarette promotes arteriosclerotic plaque development. Circulation. 1994;90:1363-1367.
4. Penn A, Batastini G, Solomon J, Burns F, Albert R. Dose-dependent size increases of aortic lesions following chronic exposure to 7,12 dimethylbenz(a)anthracene Cancer Res. 1981;41: 588-592.
5. Penn A, Batastini G, Albert RE. Age-dependent changes in prevalence, size and proliferation of arterial lesions in cockerels, II: carcinogen-associated lesions. Artery. 1981;9:382-393.
6. Penn A, Snyder CA. Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis. 1988;9:2185-2189.
7. Juchau M, Bond J, Benditt EP. Aryl-4-mono-oxygenase and cytochrome P-450 in the aorta: possible role in atherosclerosis. Proc Natl Acad Sci U S A. 1976;73:3723-3725.
8. Bond J, Omiecinski C, Juchau M. Kinetics, activation and induction of aortic mono-oxygenases-biotransformation of benzo(a)pyrene. Biochem Pharm. 1979;28:305-311.
9. Bond J, Kocan R, Benditt EP, Juchau M. Oxidative and non-oxidative metabolism of polycyclic aromatic hydrocarbons in rabbit and chicken aortas and in human fetal aortic smooth muscle cells. In: Bjorseth A, Dennis A, eds. Polycyclic Aromatic Hydrocarbons: Chemistry and Biological Effects. Columbus, Ohio: Batelle Press; 1980:489-503.
10. Majesky M, Yang H-Y, Benditt EP, Juchau M. Carcinogenesis and atherogenesis: differences in monooxygenase inducibility and bioactivation of benzo(a)pyrene in aortic and hepatic tissues of atherosclerosis susceptible versus resistant pigeons. Carcinogenesis. 1983;4:647-652.
11. Bond J, Kocan R, Benditt EP, Juchau M. Metabolism of benzo-[a]pyrene and 7,12-dimethylbenz(a)anthracene in cultured human fetal aortic smooth muscle cells. Life Sci. 1979;25:425-430.
12. Thirman M, Albrecht J, Krueger M, Erickson R, Cherwitz D, Park S, Gelboin H, Holtzman J. Induction of cytochrome CYP1A1 and formation of toxic metabolites of benzo(a)pyrene by rat aorta: a possible role in atherogenesis. Proc Natl Acad Sci U S A. 1994;91: 5397-5401.
13. New Cigarette Prototypes That Heat Instead of Burn Tobacco. Winston-Salem, NC: RJ Reynolds Tobacco Co; 1988.
14. Hecht SS, Chen CB, Ohmori T, Hoffmann D. Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N′-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 1980;40:298-302.
15. California Air Resources Board. Proposed Identification of 1,3 Butadiene as a Toxic Air Contaminant. Sacramento, Calif: California Environmental Protection Agency; 1991.
16. US Environmental Protection Agency. Preliminary draft list of categories and subcategories under Section 112 of the Clean Air Act. Federal Register. 1991;56:28548-28557.
17. Melnick R, Huff J. 1,3 butadiene induces cancers in experimental animals at all concentrations from 6.25 to 8000 parts per million. In: Sorsa M, Peltonen K, Vainio H, Hemminki K, eds. Butadiene and Styrene: Assessment of Health Hazards. Lyon, France: IARC Scientific Publication No. 127; 1993:309-322.
18. Owen P, Glaister J, Gaunt I, Pullinger D. Inhalation toxicity studies with 1,3 butadiene, III: two year toxicity/carcinogenicity studies in rats. Am Ind Hyg Assoc J. 1987;48:407-413.
19. Csanady G, Guengerich F, Bond J. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis. 1992;13:1143-1153.
20. Matanoski GM, Santos-Burgoa C, Schwartz L. Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry. Environ Health Perspect. 1990;86:107-118.
21. Drew R, Laskin S. Environmental inhalation chambers. In: Gay W, ed. Methods of Animal Experimentation. New York, NY: Academic Press; 1973:1-41.
22. Zar J. Biostatistical Analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall; 1984:292-305.
23. Benditt E, Benditt J. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A. 1973;70: 1753-1756.
24. Ou X, Ramos K. Benzo[a]pyrene inhibits protein kinase C activity in subcultured rat aortic smooth muscle cells. Chem Biol Interact. 1994;91:29-40.
25. Sadhu D, Merchant M, Safe S, Ramos K. Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo-[a]pyrene. Arch Biochem Biophys. 1993;300:124-131.
26. Penn A, Butler J, Snyder CA, Albert RE. Cigarette smoke and carbon monoxide do not have equivalent effects upon development of arteriosclerotic lesions. Artery. 1983;12:117-131.
27. Belinsky S, Walker V, Maronpot R, Swenberg J, Anderson M. Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to the tobacco specific nitrosamine 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia. Cancer Res. 1987;47: 6058-6065.
28. Murphy S, Heiblum R, King P, Bowman D, Davis W, Stoner G. Effect of phenethyl isothiocyanate on the metabolism of tobacco-specific nitrosamines by cultured rat oral tissue. Carcinogenesis. 1991;12:957-961.
29. Devereux T, Anderson M, Belinsky S. Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. Carcinogenesis. 1991;12:299-303.
30. Castonguay A, Stoner G, Schut H, Hecht S. Metabolism of tobacco-specific N-nitrosamines by cultured human tissues. Proc Natl Acad Sci U S A. 1983;80:6694-6697.
31. Klein-Szanto A, Iizasa T, Momiki S, Garcia-Palazzo I, Caamano J, Metcalf R, Welsh J, Harris C. A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc Natl Acad Sci U S A. 1992;89:6693-6697.
32. Belinsky S, White C, Devereux T, Swenberg J, Anderson M. Cell selective alkylation of DNA in rat lung following low dose exposure to the tobacco-specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 1987;47:1143-1148.
33. Crofts F, Taioli E, Trachman J, Cosma G, Currie D, Garte S. Functional significance of different human CYP1A1 genotypes. Carcinogenesis. 1994;15:2961-2963.
34. Penn A, Currie J, Snyder CA. Inhalation of carbon monoxide does not accelerate arteriosclerosis in cockerels. Eur J Pharmacol. 1992; 228:155-164.
35. Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 1988;48:6912-6917.
36. Wynder E, Hoffmann D. Tobacco and Tobacco Smoke. New York, NY: Academic Press; 1967.